China’s Innovent Biologics secures over $300 million investment from Sanofi
The all-cash investment by Sanofi unit Sanofi Foreign Participations BV will be at a price of $42.42 per Innovent share,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deals
Amgen bets on ChemoCentryx’s rare disease drug in $3.7 billion deal
Amgen has been facing stiff competition for its top-selling arthritis drug, Enbrel, from newer branded treatments and patents for…
Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma
The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
EU signs COVID-19 drug procurement deal with Gilead
The new contract comes as Europe battles a burgeoning COVID wave spearheaded by the Omicron offshoot, BA.5
Poonawalla Fincorp ties-up with AIOCD for loan offerings to its members
Through this tie-up, Poonawalla Fincorp will extend business loans, loan against property, pre-owned cars and home loans to AIOCD…
Cipla Health to acquire Endura Mass From Medinnbelle Herbalcare
The acquisition is in line with Cipla's strategic imperative to augment its wellness portfolio for bringing about a shift from an…
Pharma industry reports 61 deals worth $6.4 billion in June 2022, says GlobalData
The industry reported 115 Venture Capital (VC) deals worth $3.7 billion in June 2022, compared to the last 12-month average (June…
AstraZeneca to acquire TeneoTwo
NB-486 will be evaluated in multiple types of lymphoma
Oxford Biomedica signs new deal to make AstraZeneca COVID shot
Under the expanded deal, AstraZeneca will have access to Oxford Biomedica’s Oxbox manufacturing facility to produce its shot on an…
JB Pharma acquires four paediatric brands from Dr Reddy’s Laboratories
The total covered market size of four brands – Z&D, Pedicloryl, Pecef and Ezinapi combined is Rs 1800 crores